[Double t (3; 21) in acute myelomonocytic leukemia transformed from chronic myelomonocytic leukemia]. 2002

Yukihiro Arai, and Tomoyuki Handa, and Fumihiko Nakamura, and Wataru Takahashi, and Kazuhiro Maki, and Kinuko Mitani
Department of Hematology, Dokkyo University School of Medicine.

A 63-year-old male was diagnosed as chronic myelomonocytic leukemia with normal karyotype in September 1998. He developed acute myelogenous leukemia (AML-M4Eo) in September 2001. The cytogenetic analysis disclosed double t(3;21) at a ratio of 1/20, and the reverse transcriptase-polymerase chain reaction showed AML1/EVI-1 mRNA. He could not achieve complete remission after two courses of induction chemotherapy, and his leukemia cells carrying double t(3;21) were relatively increased. He died of interstitial pneumonia in December 2001. This is the first leukemia case with double t(3;21) and this chromosomal abnormality might play a role in leukemia cell proliferation by generating two AML1/EVI-1 genes.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002891 Chromosomes, Human, Pair 21 A specific pair of GROUP G CHROMOSOMES of the human chromosome classification. Chromosome 21
D002893 Chromosomes, Human, Pair 3 A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification. Chromosome 3
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014178 Translocation, Genetic A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome. Chromosomal Translocation,Translocation, Chromosomal,Chromosomal Translocations,Genetic Translocation,Genetic Translocations,Translocations, Chromosomal,Translocations, Genetic
D015477 Leukemia, Myelomonocytic, Chronic A myelodysplastic-myeloproliferative disease characterized by monocytosis, increased monocytes in the bone marrow, variable degrees of dysplasia, but an absence of immature granulocytes in the blood. Myelomonocytic Leukemia, Chronic,Chronic Myelomonocytic Leukemia,Chronic Myelomonocytic Leukemias,Leukemia, Chronic Myelomonocytic,Leukemias, Chronic Myelomonocytic,Myelomonocytic Leukemias, Chronic
D015479 Leukemia, Myelomonocytic, Acute A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin. Leukemia, Myeloid, Acute, M4,Leukemia, Myeloid, Naegeli-Type,Myeloid Leukemia, Acute, M4,Myeloid Leukemia, Naegeli-Type,Myelomonocytic Leukemia, Acute,Acute Myelomonocytic Leukemia,Acute Myelomonocytic Leukemias,Leukemia, Acute Myelomonocytic,Leukemia, Naegeli-Type Myeloid,Leukemias, Acute Myelomonocytic,Myeloid Leukemia, Naegeli Type,Myelomonocytic Leukemias, Acute,Naegeli-Type Myeloid Leukemia
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

Yukihiro Arai, and Tomoyuki Handa, and Fumihiko Nakamura, and Wataru Takahashi, and Kazuhiro Maki, and Kinuko Mitani
June 2015, Clinical case reports,
Yukihiro Arai, and Tomoyuki Handa, and Fumihiko Nakamura, and Wataru Takahashi, and Kazuhiro Maki, and Kinuko Mitani
June 2015, Clinical case reports,
Yukihiro Arai, and Tomoyuki Handa, and Fumihiko Nakamura, and Wataru Takahashi, and Kazuhiro Maki, and Kinuko Mitani
March 1985, Medicina clinica,
Yukihiro Arai, and Tomoyuki Handa, and Fumihiko Nakamura, and Wataru Takahashi, and Kazuhiro Maki, and Kinuko Mitani
October 2021, Current hematologic malignancy reports,
Yukihiro Arai, and Tomoyuki Handa, and Fumihiko Nakamura, and Wataru Takahashi, and Kazuhiro Maki, and Kinuko Mitani
January 1989, Japanese journal of medicine,
Yukihiro Arai, and Tomoyuki Handa, and Fumihiko Nakamura, and Wataru Takahashi, and Kazuhiro Maki, and Kinuko Mitani
December 2010, Leukemia research,
Yukihiro Arai, and Tomoyuki Handa, and Fumihiko Nakamura, and Wataru Takahashi, and Kazuhiro Maki, and Kinuko Mitani
June 2013, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Yukihiro Arai, and Tomoyuki Handa, and Fumihiko Nakamura, and Wataru Takahashi, and Kazuhiro Maki, and Kinuko Mitani
March 2014, Blood research,
Yukihiro Arai, and Tomoyuki Handa, and Fumihiko Nakamura, and Wataru Takahashi, and Kazuhiro Maki, and Kinuko Mitani
February 1987, American journal of hematology,
Yukihiro Arai, and Tomoyuki Handa, and Fumihiko Nakamura, and Wataru Takahashi, and Kazuhiro Maki, and Kinuko Mitani
March 2018, Turkish journal of haematology : official journal of Turkish Society of Haematology,
Copied contents to your clipboard!